PA

Perceptive Advisors Portfolio holdings

AUM $5.06B
1-Year Est. Return 314.02%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+314.02%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$5.06B
AUM Growth
-$396M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
136
New
Increased
Reduced
Closed

Top Buys

1
+$101M
2
+$70.2M
3
+$59.9M
4
IONS icon
Ionis Pharmaceuticals
IONS
+$39.8M
5
BCRX icon
BioCryst Pharmaceuticals
BCRX
+$33.2M

Top Sells

1
+$122M
2
+$95.6M
3
+$93.3M
4
FOLD
Amicus Therapeutics
FOLD
+$90.7M
5
ATXS
Astria Therapeutics
ATXS
+$84.9M

Sector Composition

1 Healthcare 99.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IKT icon
76
Inhibikase Therapeutics
IKT
$222M
$3.89M 0.08%
2,315,000
-3,106,568
CBIO
77
Crescent Biopharma
CBIO
$466M
$3.8M 0.08%
206,942
-246,744
APLS
78
DELISTED
Apellis Pharmaceuticals
APLS
$3.26M 0.06%
+80,956
OM icon
79
Outset Medical
OM
$88.6M
$3.2M 0.06%
833,333
EDSA icon
80
Edesa Biotech
EDSA
$60.9M
$2.95M 0.06%
+563,239
ADPT icon
81
Adaptive Biotechnologies
ADPT
$2.4B
$2.12M 0.04%
+152,500
AVTX icon
82
Avalo Therapeutics
AVTX
$746M
$2.09M 0.04%
139,667
CNTB
83
Connect Biopharma Holdings
CNTB
$150M
$2.08M 0.04%
792,696
CORT icon
84
Corcept Therapeutics
CORT
$7.69B
$2.02M 0.04%
+50,000
MDLN
85
Medline Inc
MDLN
$28.2B
$1.25M 0.02%
28,000
PTN
86
Palatin Technologies, Inc. Common Stock
PTN
$24.7M
$1.08M 0.02%
61,945
-8,055
CPIX icon
87
Cumberland Pharmaceuticals
CPIX
$83.5M
$640K 0.01%
196,978
-144,109
RVMDW icon
88
Revolution Medicines Inc Warrant
RVMDW
$66.2M
$448K 0.01%
250,000
XGN icon
89
Exagen
XGN
$113M
$345K 0.01%
+114,893
ENSC icon
90
Ensysce Biosciences
ENSC
$3.81M
$46.7K ﹤0.01%
86,666
SRZNW icon
91
Surrozen Inc Warrant
SRZNW
$2.67K ﹤0.01%
166,666
BDSX icon
92
Biodesix
BDSX
$159M
– –
-108,694
DXCM icon
93
DexCom
DXCM
$28B
– –
-225,758
EXAS
94
DELISTED
Exact Sciences
EXAS
– –
-1,200,487
IOVA icon
95
Iovance Biotherapeutics
IOVA
$1.79B
– –
-152,714
IRON icon
96
Disc Medicine
IRON
$2.6B
– –
-450,743
KRYS icon
97
Krystal Biotech
KRYS
$8.84B
– –
-17,500
NVNO
98
enVVeno Medical
NVNO
$7.35M
– –
-50,258
OCUL icon
99
Ocular Therapeutix
OCUL
$1.79B
– –
0
OLMA icon
100
Olema Pharmaceuticals
OLMA
$921M
– –
-165,713
2 3
4
5 6